Status:

WITHDRAWN

Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.

Lead Sponsor:

Norwegian University of Science and Technology

Collaborating Sponsors:

The Royal Norwegian Ministry of Health

Conditions:

Neoplasm Metastasis

Lung Neoplasms

Eligibility:

All Genders

18+ years

Brief Summary

The aim of the study is to investigate the feasibility of in vivo single volume MR spectroscopy in evaluation of treatment response in patients with brain metastases, using 3T MR instrument. In order ...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of brain metastases

Exclusion

  • children
  • pregnancy

Key Trial Info

Start Date :

November 1 2004

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2010

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00184288

Start Date

November 1 2004

End Date

December 1 2010

Last Update

November 2 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Norwegian University of Science and Technology, Faculty of Medicine

Trondheim, Norway, N-7489

Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response. | DecenTrialz